cambridge oncology centre limited
cambridge oncology centre limited Company Information
Company Number
11193611
Next Accounts
Mar 2025
Industry
Hospital activities
Shareholders
genesis cancer care uk limited
fowlmere asset management limited
View AllGroup Structure
View All
Contact
Registered Address
wilson house waterberry drive, waterlooville, hampshire, PO7 7XX
cambridge oncology centre limited Estimated Valuation
Pomanda estimates the enterprise value of CAMBRIDGE ONCOLOGY CENTRE LIMITED at £0 based on a Turnover of £0 and 0.54x industry multiple (adjusted for size and gross margin).
cambridge oncology centre limited Estimated Valuation
Pomanda estimates the enterprise value of CAMBRIDGE ONCOLOGY CENTRE LIMITED at £11.2m based on an EBITDA of £2.8m and a 4.04x industry multiple (adjusted for size and gross margin).
cambridge oncology centre limited Estimated Valuation
Pomanda estimates the enterprise value of CAMBRIDGE ONCOLOGY CENTRE LIMITED at £0 based on Net Assets of £0 and 2.7x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Cambridge Oncology Centre Limited Overview
Cambridge Oncology Centre Limited is a live company located in hampshire, PO7 7XX with a Companies House number of 11193611. It operates in the hospital activities sector, SIC Code 86101. Founded in February 2018, it's largest shareholder is genesis cancer care uk limited with a 76.1% stake. Cambridge Oncology Centre Limited is a young, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Cambridge Oncology Centre Limited Health Check
There is insufficient data available to calculate a health check for Cambridge Oncology Centre Limited. Company Health Check FAQs
0 Strong
0 Regular
2 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Cambridge Oncology Centre Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Cambridge Oncology Centre Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Cambridge Oncology Centre Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Cambridge Oncology Centre Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (49)
- Cambridge Oncology Centre Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Cambridge Oncology Centre Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Cambridge Oncology Centre Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Cambridge Oncology Centre Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Cambridge Oncology Centre Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Cambridge Oncology Centre Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Cambridge Oncology Centre Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 100%, this is a higher level of debt than the average (50.8%)
- - Cambridge Oncology Centre Limited
- - Industry AVG
CAMBRIDGE ONCOLOGY CENTRE LIMITED financials
Cambridge Oncology Centre Limited's latest turnover from June 2023 is 0 and the company has net assets of 0. According to their latest financial statements, we estimate that Cambridge Oncology Centre Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | |
|---|---|---|---|---|---|
| Turnover | 0 | 0 | 0 | 0 | 0 |
| Other Income Or Grants | 0 | 0 | 0 | ||
| Cost Of Sales | 0 | 0 | 0 | ||
| Gross Profit | 0 | 0 | 0 | ||
| Admin Expenses | -931,000 | -286,000 | -485,000 | ||
| Operating Profit | 2,763,000 | 1,811,000 | 931,000 | 286,000 | 485,000 |
| Interest Payable | 698,000 | 657,000 | 0 | 0 | 0 |
| Interest Receivable | 698,000 | 657,000 | 0 | 0 | 0 |
| Pre-Tax Profit | 566,000 | 344,000 | 931,000 | 286,000 | 485,000 |
| Tax | -566,000 | -344,000 | 0 | 0 | 0 |
| Profit After Tax | 0 | 0 | 931,000 | 286,000 | 485,000 |
| Dividends Paid | 1,467,000 | 931,000 | 286,000 | 485,000 | 0 |
| Retained Profit | -1,467,000 | -931,000 | 645,000 | -199,000 | 485,000 |
| Employee Costs | 0 | 0 | 0 | 0 | 0 |
| Number Of Employees | |||||
| EBITDA* | 2,763,000 | 1,811,000 | 931,000 | 286,000 | 485,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | |
|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 7,250,000 | 7,250,000 | 7,250,000 |
| Investments & Other | 4,754,000 | 5,452,000 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 4,754,000 | 5,452,000 | 7,250,000 | 7,250,000 | 7,250,000 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 1,091,000 | 695,000 | 931,000 | 212,000 | 411,000 |
| Misc Debtors | 0 | 0 | 0 | 74,000 | 74,000 |
| Cash | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1,091,000 | 695,000 | 931,000 | 286,000 | 485,000 |
| total assets | 5,845,000 | 6,147,000 | 8,181,000 | 7,536,000 | 7,735,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 566,000 | 344,000 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 525,000 | 351,000 | 0 | 0 | 0 |
| total current liabilities | 1,091,000 | 695,000 | 0 | 0 | 0 |
| loans | 4,754,000 | 5,452,000 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 4,754,000 | 5,452,000 | 0 | 0 | 0 |
| total liabilities | 5,845,000 | 6,147,000 | 0 | 0 | 0 |
| net assets | 0 | 0 | 8,181,000 | 7,536,000 | 7,735,000 |
| total shareholders funds | 0 | 0 | 8,181,000 | 7,536,000 | 7,735,000 |
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Operating Profit | 2,763,000 | 1,811,000 | 931,000 | 286,000 | 485,000 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 |
| Tax | -566,000 | -344,000 | 0 | 0 | 0 |
| Stock | 0 | 0 | 0 | 0 | 0 |
| Debtors | 396,000 | -236,000 | 645,000 | -199,000 | 485,000 |
| Creditors | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 174,000 | 351,000 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 1,975,000 | 2,054,000 | 286,000 | 485,000 | 0 |
| Investing Activities | |||||
| capital expenditure | |||||
| Change in Investments | -698,000 | 5,452,000 | 0 | 0 | 0 |
| cash flow from investments | |||||
| Financing Activities | |||||
| Bank loans | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 222,000 | 344,000 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 |
| Long term loans | -698,000 | 5,452,000 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||
| interest | 0 | 0 | 0 | 0 | 0 |
| cash flow from financing | 991,000 | -1,454,000 | 0 | 0 | 7,250,000 |
| cash and cash equivalents | |||||
| cash | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 |
cambridge oncology centre limited Credit Report and Business Information
Cambridge Oncology Centre Limited Competitor Analysis
Perform a competitor analysis for cambridge oncology centre limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other young companies, companies in PO7 area or any other competitors across 12 key performance metrics.
cambridge oncology centre limited Ownership
CAMBRIDGE ONCOLOGY CENTRE LIMITED group structure
Cambridge Oncology Centre Limited has no subsidiary companies.
Ultimate parent company
GENESIS CARE PTY LIMITED
#0101724
2 parents
CAMBRIDGE ONCOLOGY CENTRE LIMITED
11193611
cambridge oncology centre limited directors
Cambridge Oncology Centre Limited currently has 5 directors. The longest serving directors include Dr Simon Russell (May 2018) and Dr George Follows (Jul 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Simon Russell | England | 54 years | May 2018 | - | Director |
| Dr George Follows | United Kingdom | 56 years | Jul 2018 | - | Director |
| Mr James McArthur | England | 36 years | Mar 2019 | - | Director |
| Mr Justin Hely | 46 years | Mar 2021 | - | Director | |
| Mr Peter Allen | 46 years | Jan 2024 | - | Director |
P&L
June 2023turnover
0
0%
operating profit
2.8m
+53%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2023net assets
0
0%
total assets
5.8m
-0.05%
cash
0
0%
net assets
Total assets minus all liabilities
cambridge oncology centre limited company details
company number
11193611
Type
Private limited with Share Capital
industry
86101 - Hospital activities
incorporation date
February 2018
age
7
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
June 2023
previous names
N/A
accountant
-
auditor
PRICEWATERHOUSECOOPERS LLP
address
wilson house waterberry drive, waterlooville, hampshire, PO7 7XX
Bank
-
Legal Advisor
-
cambridge oncology centre limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to cambridge oncology centre limited. Currently there are 0 open charges and 1 have been satisfied in the past.
cambridge oncology centre limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CAMBRIDGE ONCOLOGY CENTRE LIMITED. This can take several minutes, an email will notify you when this has completed.
cambridge oncology centre limited Companies House Filings - See Documents
| date | description | view/download |
|---|
